Yendou

Berlin, Germany Founded: 2022 • Age: 4 yrs
Site engagement platform for clinical trials is provided.
Annual revenue - Latest available
Total funding $1.3M 1 rounds
Employees - Tracked headcount
Investors 4 Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Yendou

Yendou is a company based in Berlin (Germany) founded in 2022 by Zina Sarif. Yendou has raised $1.3 million across 1 funding round from investors including b2venture, Infinity Capital Partners and Meri Beckwith. Yendou offers products and services including AI Site Engagement Platform and CDA Management.

  • Headquarter Berlin, Germany
  • Founders Zina Sarif
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Yendou Gmbh
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $1.3 M (USD)

    in 1 rounds

  • Latest Funding Round
    $1.3 M (USD), Seed

    Feb 28, 2024

  • Investors
    b2venture

    & 3 more

  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Yendou

Yendou offers a comprehensive portfolio of products and services, including AI Site Engagement Platform and CDA Management.

Product name locked
Category locked
Primary

The platform is employed for automating site engagement in clinical trials, including feasibility and reporting processes.

Product name locked
Category locked
Locked

CDA management is utilized to streamline confidentiality agreements, ensuring compliance and efficient execution in trial operations.

Funding Insights of Yendou

Yendou has successfully raised a total of $1.3M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.3 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Yendou

Yendou has secured backing from 4 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include b2venture, Infinity Capital Partners and Meri Beckwith.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
Venture capital is provided to innovative startups by b2venture.
Locked Locked Locked
Venture capital fund investing in early-stage tech startups
Locked Locked Locked
Diversified assets are managed by Infinity Capital Partners in Atlanta.
Locked Locked Locked
Premium access

Investor details for Yendou

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Yendou

Investments
Premium access

Investment portfolio details for Yendou

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Yendou

Premium access

Detailed financials for Yendou

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Yendou Comparisons

Yendou Primary company
Description
Site engagement platform for clinical trials is provided.
Location
Berlin, Germany
Founded Year
2022
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Yendou

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Yendou

Premium access

Detailed competitors of Yendou

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Yendou

Premium access

Complete news archive for Yendou

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yendou

Yendou was founded in 2022 and raised its 1st funding round 2 years after it was founded.

Yendou is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.

Zina Sarif is the current CEO of Yendou. They have also founded this company.

Yendou is a funded company, having raised a total of $1.3M across 1 funding round to date.

Provider of a site engagement platform for clinical trials. This platform streamlines the process of clinical trial site identification, activation, and engagement. It consolidates site data, automates communication, and improves knowledge retention across teams. The platform facilitates efficient collaboration between sponsors, CROs, and research sites without requiring sites to use additional technology. This results in faster study timelines and reduced administrative burden for all parties involved. The platforms features include a global site directory, a knowledge retention engine, and tools for scalable, personalized engagement.

Yendou offers AI Site Engagement Platform and CDA Management.

Yendou has 4 investors. Key investors include b2venture, Infinity Capital Partners, Meri Beckwith, and HEARTFELT_.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available